Share Price and Basic Stock Data
Last Updated: October 26, 2025, 9:22 am
| PEG Ratio | 11.92 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Navin Fluorine International Ltd operates in the chemicals sector, focusing on specialty chemicals, which has shown considerable revenue growth. For the fiscal year ending March 2023, the company reported sales of ₹2,077 Cr, a significant increase from ₹1,453 Cr in March 2022. This upward trajectory continued, with trailing twelve-month (TTM) sales reaching ₹2,551 Cr. Quarterly sales figures have demonstrated volatility, peaking at ₹697 Cr in March 2023 before dropping to ₹491 Cr in June 2023. However, sales rebounded in subsequent quarters, recording ₹602 Cr in March 2024 and ₹701 Cr in March 2025. The company’s operational focus appears to be enhancing its portfolio, which is evident in its commitment to expanding production capacities and diversifying its product offerings. This strategic alignment with market demands positions Navin Fluorine favorably for sustained growth.
Profitability and Efficiency Metrics
Navin Fluorine’s profitability metrics reflect a robust operational framework, albeit with some fluctuations. For the fiscal year ending March 2025, the company reported a net profit of ₹289 Cr, down from ₹375 Cr in the previous year. The operating profit margin (OPM) stood at 23% for March 2025, while the return on equity (ROE) was reported at 10.98%. A notable aspect of its profitability is the interest coverage ratio (ICR), which stood at 7.41x, indicating a strong capacity to meet interest obligations. However, the company’s net profit margin declined to 12.28% in March 2025 from 18.06% in March 2023, highlighting potential pressures on profitability. Additionally, the cash conversion cycle (CCC) stood at 89 days, reflecting operational efficiency but suggesting room for improvement in working capital management. Overall, while profitability remains healthy, the company must address the declining margins to sustain investor confidence.
Balance Sheet Strength and Financial Ratios
Navin Fluorine’s balance sheet exhibits a solid foundation, characterized by a market capitalization of ₹26,569 Cr and total borrowings amounting to ₹1,466 Cr. The company’s reserves have increased to ₹2,616 Cr, showcasing a strong equity base. The debt-to-equity ratio stood at 0.54, indicating a balanced approach to financing its operations without over-leveraging. Additionally, the company’s current ratio of 1.74 suggests a healthy liquidity position, allowing it to cover short-term liabilities effectively. The price-to-book value ratio (P/BV) is reported at 7.95x, which is relatively high, indicating that the stock may be priced for growth. Furthermore, the return on capital employed (ROCE) was reported at 11.69%, reflecting efficient use of capital in generating profits. These financial ratios collectively underscore Navin Fluorine’s strong balance sheet and prudent financial management practices.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Navin Fluorine International Ltd reflects a diverse and stable investor base, which is crucial for long-term confidence. As of March 2025, promoters held 28.43% of the company, while foreign institutional investors (FIIs) held 22.15%. Domestic institutional investors (DIIs) accounted for 29.57%, indicating significant institutional interest. The public shareholding stood at 21.16%, with the number of shareholders reported at 1,37,981. Over recent quarters, there has been a slight decline in promoter holdings, which may raise concerns about insider confidence; however, the stable institutional presence suggests strong market validation of the company’s prospects. The increasing stake of domestic and foreign institutional investors signals growing confidence in Navin Fluorine’s growth trajectory, despite the slight fluctuations in promoter shareholding.
Outlook, Risks, and Final Insight
Navin Fluorine International Ltd faces a mixed outlook based on its recent performance metrics. The company has shown considerable revenue growth and maintains a robust balance sheet, supported by strong institutional investor interest. However, the decline in net profit margins and OPM raises potential concerns about profitability sustainability amidst rising operational costs. Risks include market volatility affecting demand for specialty chemicals and possible fluctuations in raw material prices, which could impact margins. Additionally, the company’s reliance on debt financing could pose risks if interest rates rise. To navigate these challenges, management may need to enhance operational efficiencies and explore cost-control measures. Overall, while Navin Fluorine is well-positioned in the specialty chemicals market, it must address profitability pressures to maintain its growth trajectory and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Navin Fluorine International Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 284 Cr. | 290 | 577/288 | 171 | 165 | 0.34 % | 3.33 % | 1.78 % | 10.0 |
| Deco-Mica Ltd | 34.0 Cr. | 81.0 | 97.0/56.0 | 14.9 | 64.1 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,062 Cr. | 78.3 | 108/64.9 | 19.7 | 117 | 1.02 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 1,032 Cr. | 115 | 119/63.6 | 14.4 | 101 | 1.05 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 91,358 Cr. | 3,082 | 3,325/2,127 | 63.8 | 426 | 0.23 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,266.44 Cr | 1,100.56 | 50.44 | 182.76 | 0.38% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 398 | 419 | 564 | 697 | 491 | 472 | 500 | 602 | 524 | 519 | 606 | 701 | 725 |
| Expenses | 298 | 325 | 408 | 495 | 377 | 373 | 424 | 492 | 423 | 411 | 459 | 522 | 519 |
| Operating Profit | 99 | 94 | 156 | 202 | 114 | 98 | 76 | 110 | 100 | 107 | 147 | 179 | 207 |
| OPM % | 25% | 22% | 28% | 29% | 23% | 21% | 15% | 18% | 19% | 21% | 24% | 26% | 29% |
| Other Income | 11 | 11 | 10 | 4 | 8 | 23 | 64 | 13 | 10 | 11 | 10 | 12 | 14 |
| Interest | 0 | 4 | 9 | 14 | 19 | 20 | 18 | 17 | 16 | 14 | 20 | 28 | 30 |
| Depreciation | 12 | 18 | 25 | 8 | 21 | 24 | 25 | 26 | 27 | 28 | 30 | 35 | 35 |
| Profit before tax | 97 | 83 | 131 | 184 | 82 | 77 | 97 | 79 | 68 | 77 | 108 | 127 | 155 |
| Tax % | 24% | 30% | 19% | 26% | 25% | 22% | 20% | 11% | 25% | 23% | 23% | 25% | 24% |
| Net Profit | 74 | 58 | 107 | 136 | 62 | 61 | 78 | 70 | 51 | 59 | 84 | 95 | 117 |
| EPS in Rs | 15.02 | 11.67 | 21.50 | 27.50 | 12.41 | 12.22 | 15.74 | 14.19 | 10.32 | 11.86 | 16.86 | 19.15 | 23.62 |
Last Updated: August 1, 2025, 4:30 pm
Below is a detailed analysis of the quarterly data for Navin Fluorine International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 725.00 Cr.. The value appears strong and on an upward trend. It has increased from 701.00 Cr. (Mar 2025) to 725.00 Cr., marking an increase of 24.00 Cr..
- For Expenses, as of Jun 2025, the value is 519.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 522.00 Cr. (Mar 2025) to 519.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 207.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2025) to 207.00 Cr., marking an increase of 28.00 Cr..
- For OPM %, as of Jun 2025, the value is 29.00%. The value appears strong and on an upward trend. It has increased from 26.00% (Mar 2025) to 29.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 35.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 127.00 Cr. (Mar 2025) to 155.00 Cr., marking an increase of 28.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Mar 2025) to 24.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 22.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 23.62. The value appears strong and on an upward trend. It has increased from 19.15 (Mar 2025) to 23.62, marking an increase of 4.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:24 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 486 | 592 | 680 | 742 | 913 | 996 | 1,062 | 1,179 | 1,453 | 2,077 | 2,065 | 2,349 | 2,551 |
| Expenses | 420 | 519 | 561 | 582 | 693 | 777 | 794 | 870 | 1,098 | 1,527 | 1,666 | 1,816 | 1,911 |
| Operating Profit | 66 | 72 | 118 | 159 | 220 | 219 | 268 | 309 | 356 | 550 | 399 | 534 | 640 |
| OPM % | 14% | 12% | 17% | 21% | 24% | 22% | 25% | 26% | 24% | 26% | 19% | 23% | 25% |
| Other Income | 31 | 29 | 23 | 55 | 88 | 34 | 29 | 94 | 38 | 36 | 107 | 44 | 47 |
| Interest | 6 | 3 | 4 | 3 | 1 | 1 | 2 | 2 | 2 | 28 | 75 | 78 | 93 |
| Depreciation | 22 | 20 | 22 | 30 | 40 | 28 | 37 | 44 | 48 | 63 | 96 | 119 | 128 |
| Profit before tax | 69 | 78 | 116 | 182 | 266 | 224 | 258 | 358 | 344 | 496 | 336 | 380 | 467 |
| Tax % | 21% | 26% | 28% | 25% | 32% | 34% | -56% | 31% | 24% | 24% | 19% | 24% | |
| Net Profit | 68 | 58 | 84 | 137 | 180 | 149 | 409 | 258 | 263 | 375 | 270 | 289 | 355 |
| EPS in Rs | 13.47 | 11.18 | 17.08 | 27.88 | 36.43 | 30.15 | 82.57 | 52.02 | 53.09 | 75.68 | 54.56 | 58.19 | 71.49 |
| Dividend Payout % | 24% | 29% | 25% | 23% | 27% | 26% | 13% | 21% | 21% | 16% | 27% | 12% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -14.71% | 44.83% | 63.10% | 31.39% | -17.22% | 174.50% | -36.92% | 1.94% | 42.59% | -28.00% | 7.04% |
| Change in YoY Net Profit Growth (%) | 0.00% | 59.53% | 18.27% | -31.71% | -48.61% | 191.72% | -211.42% | 38.86% | 40.65% | -70.59% | 35.04% |
Navin Fluorine International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 17% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | -7% |
| 3 Years: | 3% |
| TTM: | 62% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 19% |
| 3 Years: | 4% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 14% |
| 3 Years: | 13% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 11:35 am
Balance Sheet
Last Updated: July 25, 2025, 2:41 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 546 | 578 | 636 | 825 | 974 | 1,063 | 1,402 | 1,624 | 1,834 | 2,175 | 2,373 | 2,616 |
| Borrowings | 58 | 61 | 82 | 19 | 13 | 4 | 1 | 25 | 121 | 861 | 1,368 | 1,466 |
| Other Liabilities | 166 | 203 | 228 | 324 | 259 | 231 | 215 | 239 | 420 | 484 | 626 | 738 |
| Total Liabilities | 779 | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 |
| Fixed Assets | 288 | 274 | 375 | 561 | 428 | 430 | 529 | 540 | 556 | 1,646 | 1,875 | 2,736 |
| CWIP | 6 | 60 | 20 | 17 | 20 | 39 | 39 | 95 | 742 | 279 | 711 | 355 |
| Investments | 230 | 171 | 170 | 239 | 428 | 427 | 195 | 99 | 118 | 44 | 495 | 480 |
| Other Assets | 255 | 346 | 390 | 360 | 380 | 410 | 866 | 1,163 | 969 | 1,561 | 1,296 | 1,259 |
| Total Assets | 779 | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 |
Below is a detailed analysis of the balance sheet data for Navin Fluorine International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,616.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,373.00 Cr. (Mar 2024) to 2,616.00 Cr., marking an increase of 243.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1,466.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,368.00 Cr. (Mar 2024) to 1,466.00 Cr., marking an increase of 98.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 738.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 626.00 Cr. (Mar 2024) to 738.00 Cr., marking an increase of 112.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 4,830.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,377.00 Cr. (Mar 2024) to 4,830.00 Cr., marking an increase of 453.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2,736.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,875.00 Cr. (Mar 2024) to 2,736.00 Cr., marking an increase of 861.00 Cr..
- For CWIP, as of Mar 2025, the value is 355.00 Cr.. The value appears to be declining and may need further review. It has decreased from 711.00 Cr. (Mar 2024) to 355.00 Cr., marking a decrease of 356.00 Cr..
- For Investments, as of Mar 2025, the value is 480.00 Cr.. The value appears to be declining and may need further review. It has decreased from 495.00 Cr. (Mar 2024) to 480.00 Cr., marking a decrease of 15.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,259.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,296.00 Cr. (Mar 2024) to 1,259.00 Cr., marking a decrease of 37.00 Cr..
- For Total Assets, as of Mar 2025, the value is 4,830.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,377.00 Cr. (Mar 2024) to 4,830.00 Cr., marking an increase of 453.00 Cr..
Notably, the Reserves (2,616.00 Cr.) exceed the Borrowings (1,466.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 8.00 | 11.00 | 36.00 | 140.00 | 207.00 | 215.00 | 267.00 | 284.00 | 235.00 | -311.00 | 398.00 | 533.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68 | 74 | 81 | 68 | 62 | 63 | 75 | 88 | 90 | 99 | 91 | 90 |
| Inventory Days | 105 | 96 | 89 | 136 | 110 | 91 | 127 | 129 | 149 | 197 | 150 | 117 |
| Days Payable | 97 | 113 | 112 | 94 | 92 | 58 | 79 | 77 | 85 | 103 | 122 | 118 |
| Cash Conversion Cycle | 75 | 57 | 57 | 110 | 80 | 96 | 123 | 140 | 154 | 193 | 119 | 89 |
| Working Capital Days | 24 | 39 | 37 | 4 | 43 | 58 | 88 | 113 | 109 | 140 | 45 | 25 |
| ROCE % | 11% | 11% | 17% | 22% | 29% | 21% | 21% | 22% | 19% | 20% | 11% | 12% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 700,000 | 0.96 | 239.23 | 700,000 | 2025-04-22 14:12:25 | 0% |
| ICICI Prudential Flexicap Fund | 206,893 | 0.51 | 70.71 | 206,893 | 2025-04-22 15:56:55 | 0% |
| ICICI Prudential India Opportunities Fund | 197,687 | 0.42 | 67.56 | 197,687 | 2025-04-22 15:56:55 | 0% |
| HDFC Large and Mid Cap Fund - Regular Plan | 136,771 | 0.29 | 46.74 | 136,771 | 2025-04-22 15:56:55 | 0% |
| ICICI Prudential MidCap Fund | 129,000 | 0.81 | 44.09 | 129,000 | 2025-04-22 15:56:55 | 0% |
| UTI Small Cap Fund | 117,997 | 1.08 | 40.33 | 117,997 | 2025-04-22 15:56:55 | 0% |
| HDFC Multi Cap Fund | 106,426 | 0.31 | 36.37 | 106,426 | 2025-04-22 15:56:55 | 0% |
| HSBC Mid Cap Fund - OLD | 65,000 | 2.73 | 29.59 | 65,000 | 2025-04-22 15:56:55 | 0% |
| L&T Large and Midcap Fund - Regular Plan | 51,900 | 1.46 | 23.62 | 51,900 | 2025-04-22 15:56:55 | 0% |
| ICICI Prudential Regular Savings Fund | 61,627 | 0.57 | 19.27 | 61,627 | 2025-04-22 15:56:55 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 58.20 | 54.57 | 75.70 | 53.12 | 52.03 |
| Diluted EPS (Rs.) | 58.14 | 54.49 | 75.44 | 53.08 | 51.96 |
| Cash EPS (Rs.) | 82.26 | 74.00 | 88.36 | 62.76 | 58.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 529.48 | 480.86 | 440.96 | 372.19 | 330.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 529.48 | 480.86 | 440.96 | 372.19 | 330.11 |
| Revenue From Operations / Share (Rs.) | 473.67 | 416.75 | 419.25 | 293.31 | 238.28 |
| PBDIT / Share (Rs.) | 116.42 | 91.65 | 118.27 | 79.52 | 78.46 |
| PBIT / Share (Rs.) | 92.34 | 72.24 | 105.63 | 69.85 | 69.53 |
| PBT / Share (Rs.) | 76.63 | 67.72 | 100.08 | 69.47 | 72.30 |
| Net Profit / Share (Rs.) | 58.19 | 54.59 | 75.72 | 53.09 | 49.91 |
| NP After MI And SOA / Share (Rs.) | 58.18 | 54.59 | 75.72 | 53.09 | 52.03 |
| PBDIT Margin (%) | 24.57 | 21.99 | 28.21 | 27.11 | 32.92 |
| PBIT Margin (%) | 19.49 | 17.33 | 25.19 | 23.81 | 29.18 |
| PBT Margin (%) | 16.17 | 16.24 | 23.87 | 23.68 | 30.34 |
| Net Profit Margin (%) | 12.28 | 13.09 | 18.06 | 18.10 | 20.94 |
| NP After MI And SOA Margin (%) | 12.28 | 13.09 | 18.06 | 18.10 | 21.83 |
| Return on Networth / Equity (%) | 10.98 | 11.35 | 17.17 | 14.26 | 15.76 |
| Return on Capital Employeed (%) | 11.69 | 10.17 | 17.40 | 17.29 | 20.29 |
| Return On Assets (%) | 5.97 | 6.18 | 10.63 | 11.02 | 13.57 |
| Long Term Debt / Equity (X) | 0.40 | 0.42 | 0.34 | 0.05 | 0.00 |
| Total Debt / Equity (X) | 0.54 | 0.56 | 0.38 | 0.05 | 0.00 |
| Asset Turnover Ratio (%) | 0.51 | 0.52 | 0.67 | 0.69 | 0.64 |
| Current Ratio (X) | 1.74 | 1.81 | 2.81 | 2.65 | 5.91 |
| Quick Ratio (X) | 1.38 | 1.38 | 1.91 | 1.98 | 5.02 |
| Inventory Turnover Ratio (X) | 6.77 | 2.15 | 2.47 | 3.15 | 3.33 |
| Dividend Payout Ratio (NP) (%) | 20.61 | 27.48 | 14.53 | 20.70 | 15.37 |
| Dividend Payout Ratio (CP) (%) | 14.58 | 20.28 | 12.45 | 17.51 | 13.12 |
| Earning Retention Ratio (%) | 79.39 | 72.52 | 85.47 | 79.30 | 84.63 |
| Cash Earning Retention Ratio (%) | 85.42 | 79.72 | 87.55 | 82.49 | 86.88 |
| Interest Coverage Ratio (X) | 7.41 | 6.09 | 21.30 | 207.38 | 211.21 |
| Interest Coverage Ratio (Post Tax) (X) | 4.70 | 3.93 | 14.63 | 139.46 | 126.93 |
| Enterprise Value (Cr.) | 22273.63 | 16732.36 | 21948.40 | 20235.45 | 13070.56 |
| EV / Net Operating Revenue (X) | 9.48 | 8.10 | 10.57 | 13.92 | 11.08 |
| EV / EBITDA (X) | 38.57 | 36.84 | 37.45 | 51.35 | 33.66 |
| MarketCap / Net Operating Revenue (X) | 8.88 | 7.47 | 10.17 | 13.92 | 11.54 |
| Retention Ratios (%) | 79.38 | 72.51 | 85.46 | 79.29 | 84.62 |
| Price / BV (X) | 7.95 | 6.47 | 9.67 | 10.97 | 8.33 |
| Price / Net Operating Revenue (X) | 8.88 | 7.47 | 10.17 | 13.92 | 11.54 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Navin Fluorine International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 58.20. This value is within the healthy range. It has increased from 54.57 (Mar 24) to 58.20, marking an increase of 3.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 58.14. This value is within the healthy range. It has increased from 54.49 (Mar 24) to 58.14, marking an increase of 3.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 82.26. This value is within the healthy range. It has increased from 74.00 (Mar 24) to 82.26, marking an increase of 8.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 529.48. It has increased from 480.86 (Mar 24) to 529.48, marking an increase of 48.62.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 529.48. It has increased from 480.86 (Mar 24) to 529.48, marking an increase of 48.62.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 473.67. It has increased from 416.75 (Mar 24) to 473.67, marking an increase of 56.92.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 116.42. This value is within the healthy range. It has increased from 91.65 (Mar 24) to 116.42, marking an increase of 24.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 92.34. This value is within the healthy range. It has increased from 72.24 (Mar 24) to 92.34, marking an increase of 20.10.
- For PBT / Share (Rs.), as of Mar 25, the value is 76.63. This value is within the healthy range. It has increased from 67.72 (Mar 24) to 76.63, marking an increase of 8.91.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.19. This value is within the healthy range. It has increased from 54.59 (Mar 24) to 58.19, marking an increase of 3.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.18. This value is within the healthy range. It has increased from 54.59 (Mar 24) to 58.18, marking an increase of 3.59.
- For PBDIT Margin (%), as of Mar 25, the value is 24.57. This value is within the healthy range. It has increased from 21.99 (Mar 24) to 24.57, marking an increase of 2.58.
- For PBIT Margin (%), as of Mar 25, the value is 19.49. This value is within the healthy range. It has increased from 17.33 (Mar 24) to 19.49, marking an increase of 2.16.
- For PBT Margin (%), as of Mar 25, the value is 16.17. This value is within the healthy range. It has decreased from 16.24 (Mar 24) to 16.17, marking a decrease of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 12.28. This value exceeds the healthy maximum of 10. It has decreased from 13.09 (Mar 24) to 12.28, marking a decrease of 0.81.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.28. This value is within the healthy range. It has decreased from 13.09 (Mar 24) to 12.28, marking a decrease of 0.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.98. This value is below the healthy minimum of 15. It has decreased from 11.35 (Mar 24) to 10.98, marking a decrease of 0.37.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.69. This value is within the healthy range. It has increased from 10.17 (Mar 24) to 11.69, marking an increase of 1.52.
- For Return On Assets (%), as of Mar 25, the value is 5.97. This value is within the healthy range. It has decreased from 6.18 (Mar 24) to 5.97, marking a decrease of 0.21.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has decreased from 0.42 (Mar 24) to 0.40, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.56 (Mar 24) to 0.54, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.51. It has decreased from 0.52 (Mar 24) to 0.51, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.74, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 1.38. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.38.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.77. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 6.77, marking an increase of 4.62.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.61. This value is within the healthy range. It has decreased from 27.48 (Mar 24) to 20.61, marking a decrease of 6.87.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.58. This value is below the healthy minimum of 20. It has decreased from 20.28 (Mar 24) to 14.58, marking a decrease of 5.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.39. This value exceeds the healthy maximum of 70. It has increased from 72.52 (Mar 24) to 79.39, marking an increase of 6.87.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.42. This value exceeds the healthy maximum of 70. It has increased from 79.72 (Mar 24) to 85.42, marking an increase of 5.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.41. This value is within the healthy range. It has increased from 6.09 (Mar 24) to 7.41, marking an increase of 1.32.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.70. This value is within the healthy range. It has increased from 3.93 (Mar 24) to 4.70, marking an increase of 0.77.
- For Enterprise Value (Cr.), as of Mar 25, the value is 22,273.63. It has increased from 16,732.36 (Mar 24) to 22,273.63, marking an increase of 5,541.27.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.48. This value exceeds the healthy maximum of 3. It has increased from 8.10 (Mar 24) to 9.48, marking an increase of 1.38.
- For EV / EBITDA (X), as of Mar 25, the value is 38.57. This value exceeds the healthy maximum of 15. It has increased from 36.84 (Mar 24) to 38.57, marking an increase of 1.73.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.88. This value exceeds the healthy maximum of 3. It has increased from 7.47 (Mar 24) to 8.88, marking an increase of 1.41.
- For Retention Ratios (%), as of Mar 25, the value is 79.38. This value exceeds the healthy maximum of 70. It has increased from 72.51 (Mar 24) to 79.38, marking an increase of 6.87.
- For Price / BV (X), as of Mar 25, the value is 7.95. This value exceeds the healthy maximum of 3. It has increased from 6.47 (Mar 24) to 7.95, marking an increase of 1.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.88. This value exceeds the healthy maximum of 3. It has increased from 7.47 (Mar 24) to 8.88, marking an increase of 1.41.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Navin Fluorine International Ltd:
- Net Profit Margin: 12.28%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.69% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.98% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.7
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.38
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 73.1 (Industry average Stock P/E: 50.44)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.54
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.28%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | Office No. 602, 6th floor, Natraj by Rustomjee, Mumbai Maharashtra 400069 | info@nfil.in http://www.nfil.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vishad P Mafatlal | Executive Chairman |
| Mr. Nitin G Kulkarni | Managing Director |
| Mr. Sudhir R Deo | Non Exe.Non Ind.Director |
| Mr. Atul K Srivastava | Independent Director |
| Mr. Ashok U Sinha | Independent Director |
| Mr. Sujal A Shah | Independent Director |
| Mr. Apurva S Purohit | Independent Director |
| Mr. Abhijit J Joshi | Independent Director |
FAQ
What is the intrinsic value of Navin Fluorine International Ltd?
Navin Fluorine International Ltd's intrinsic value (as of 26 October 2025) is 3572.91 which is 29.33% lower the current market price of 5,056.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 25,903 Cr. market cap, FY2025-2026 high/low of 5,444/3,180, reserves of ₹2,616 Cr, and liabilities of 4,830 Cr.
What is the Market Cap of Navin Fluorine International Ltd?
The Market Cap of Navin Fluorine International Ltd is 25,903 Cr..
What is the current Stock Price of Navin Fluorine International Ltd as on 26 October 2025?
The current stock price of Navin Fluorine International Ltd as on 26 October 2025 is 5,056.
What is the High / Low of Navin Fluorine International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Navin Fluorine International Ltd stocks is 5,444/3,180.
What is the Stock P/E of Navin Fluorine International Ltd?
The Stock P/E of Navin Fluorine International Ltd is 73.1.
What is the Book Value of Navin Fluorine International Ltd?
The Book Value of Navin Fluorine International Ltd is 530.
What is the Dividend Yield of Navin Fluorine International Ltd?
The Dividend Yield of Navin Fluorine International Ltd is 0.24 %.
What is the ROCE of Navin Fluorine International Ltd?
The ROCE of Navin Fluorine International Ltd is 11.7 %.
What is the ROE of Navin Fluorine International Ltd?
The ROE of Navin Fluorine International Ltd is 11.5 %.
What is the Face Value of Navin Fluorine International Ltd?
The Face Value of Navin Fluorine International Ltd is 2.00.